BioSpace News Archive

Deals

Impax Shareholders Approve Proposed Business Combination with Amneal

Impax Laboratories, Inc. announced that at its special meeting of stockholders held today, Impax stockholders overwhelmingly approved the previously announced business combination of Impax with Amneal Pharmaceuticals LLC.

March 27, 2018
·
2 min read
BioMidwest

Survey Finds Reducing Stigma Attributed To Alzheimer’s Disease Vital To Prevention Research

Stigma associated with Alzheimer’s disease may be an obstacle for individuals to seek information about their risk of developing Alzheimer’s disease and to participate in clinical studies that discover potential therapies, according to the survey results.

March 27, 2018
·
4 min read
Biotech Beach

ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study

Prostate cancer study with Serametrix in which data from a previous collaboration between Serametrix and Memorial Sloan Kettering Cancer Center (MSK) was re-evaluated using ITUS technology.

March 27, 2018
·
5 min read
Drug Development

Intact Vascular Welcomes TOBA BTK Trial One-Year Clinical Study Results Publication in Catheterization and Cardiovascular Intervention

Multi-center pilot study focused on collecting data supporting the safety and performance of the Tack Endovascular System® in subjects with Critical Limb Ischemia (CLI) due to vascular disease below the knee.

March 27, 2018
·
4 min read
Business

Acessa Health Expands Leadership Team with Key Executive Hires

The company has strengthened its existing leadership team through the appointment of three experts in medical device and healthcare business operations.

March 27, 2018
·
4 min read
Job Trends

Study Finds Impact on Endurance Athlete Performance with Electric Field-Generating Compression Garments

Compression Garments Embedded with Patented V.DoxTM Technology from Vomaris

March 27, 2018
·
5 min read
Drug Development

Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B

ARO-HBV is the second clinical candidate developed using Arrowhead’s proprietary Targeted RNAi Molecule (TRiMTM) technology.

March 27, 2018
·
3 min read
Job Trends

ForeverGreen Announces New Product Sales are Exceeding Expectations

Sales lead by the global express model products PowerStrips and newly released Frequensea Pro

March 27, 2018
·
2 min read
Business

Cardax Reports 2017 Results

Strong Revenue Growth in First Full Year of ZanthoSyn® Sales

March 27, 2018
·
4 min read
Deals

WCG (WIRB-Copernicus Group) Clinical Services Division Acquires ACI Clinical

WCG Clinical Services Division expands portfolio to include the industry leader in Endpoint Adjudication and Data Monitoring Safety Committees

March 27, 2018
·
2 min read